DaVita, Inc. (NYSE: DVA) reported Q2 EPS of $0.95, $0.06 better than the analyst estimate of $0.89. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.1 billion.

Outlook

• "We are updating our consolidated operating income guidance for 2014 to now be in the range of $1.755 billion to $1.840 billion. Our previous consolidated operating income guidance for 2014 was in the range of $1.725 billion to $1.840 billion.
• We are also updating our operating income guidance for our dialysis services and related ancillary businesses including our corporate level expenses, which we refer to as Kidney Care, for 2014 to now be in the range of $1.550 billion to $1.600 billion. Our previous operating income guidance for Kidney Care for 2014 was in the range of $1.520 billion to $1.580 billion.
• We are lowering the high end of our operating income guidance for HCP for 2014 to now be in the range of $205 million to $240 million. Our previous operating income guidance for HCP for 2014 was in the range of $205 million to $260 million.
• We still expect our consolidated operating cash flow for 2014 to be in the range of $1.450 billion to $1.550 billion.

For earnings history and earnings-related data on DaVita, Inc. (DVA) click here.